Questioning Medicine artwork

Episode 257: 256. EMPEROR-Reduced- Cardiovascular Outcomes with Empagliflozin in Heart Failure

Questioning Medicine

English - March 14, 2024 00:00 - 9 minutes - 9.75 MB - ★★★★★ - 63 ratings
Medicine Health & Fitness health education medicine hospital general family health & fitness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Episode 256: 256. DAPA-HF- Dapagliflozin and Heart Failure with Reduced Ejection Fraction - DAPA-HF
Next Episode: Episode 258: 258. SOLOIST-WHF -- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure


NNT of 20 to prevent 1 hospitalization at 16 months of follow up

They composite outcome was driven by decrease hospitalizations NOT death

https://www.nejm.org/doi/full/10.1056/NEJMoa2022190